Literature DB >> 5007046

Triiodothyronine radioimmunoassay.

J Lieblich, R D Utiger.   

Abstract

Highly specific antisera to triiodothyronine (T(3)) were prepared by immunization of rabbits with T(3)-bovine serum albumin conjugates. Antisera with T(3) binding capacity of up to 600 ng/ml were obtained. The ability of various thyronine derivatives to inhibit the binding of T(3-) (125)I to anti-T(3) serum was found to vary considerably. l-T(3), d-T(3) and several triiodoanalogues were potent inhibitors of the reaction. Little inhibition of T(3-) (125)I binding was produced by l-thyroxine (T(4)) or other tetraiodo- analogues, thyronine or iodotyrosines. Chromatography of several T(4) preparations indicated that most of their very slight activity could be ascribed to contamination with T(3). Successful assay of T(3) in serum was accomplished by the addition of diphenylhydantoin to the assay system. Under these circumstances, recovery of T(3) added to serum was excellent, and addition of T(4) was without significant effect. Serum T(3) concentrations in normal subjects averaged 145 +/-25 ng/100 ml (sd). Increased concentrations (429 +/-146 ng/100 ml) were observed in hyperthyroid patients whereas those with hypothyroidism had serum T(3) levels of 99 +/-24 ng/100 ml. Elevated T(3) concentrations were found also in hypothyroid patients receiving 25 mug or more of T(3) daily and in those receiving 300 mug of T(4) daily. Serial measurements of T(3) concentrations in subjects after oral T(3) administration revealed peak T(3) concentrations 2-4 hr after T(3) administration. Intramuscular administration of thyrotropin (TSH) resulted in earlier and more pronounced increases in serum T(3) than in serum T(4) concentrations. Triiodothyronine (T(3))(1) was recognized to be a biologically active secretory product of the thyroid gland over a decade ago (1). Recent studies have indicated that it is formed extrathyroidally as well (2, 3). Nevertheless, relatively little information concerning the role of T(3) secretion in different thyroid disorders has been accumulated until very recently. Methods for the measurement of T(3) which require its extraction from plasma, and often its separation from thyroxine as well, have been described by several investigators (4-11). These methods have proven useful, but they are relatively complicated, the number of samples that can be assayed is limited, and they may be affected by in vitro deiodination of thyroxine. More recently the radioimmunoassay technique has been applied to the measurement of T(3). Several preliminary reports have appeared describing the preparation of antibody to triiodothyronine by immunization of animals with T(3)-protein conjugates and its use for the measurement of T(3) in serum (12-15). The present report describes the development of a radioimmunoassay for the measurement of T(3), studies of the specificity of the anti-T(3) serum, and some initial studies which indicate that the method is applicable to the measurement of T(3) in unextracted serum.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5007046      PMCID: PMC332941          DOI: 10.1172/JCI106786

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  DIFFERENCES IN THE INTERACTION OF TRIIODOTHYRONINE-131-I WITH SERUM PROTEINS IN VITRO.

Authors:  M L MITCHELL; A H BRADFORD; S COLLINS
Journal:  J Clin Endocrinol Metab       Date:  1964-09       Impact factor: 5.958

2.  SEPARATION OF SOME IODOAMINO ACIDS AND IODIDE BY GEL FILTRATION.

Authors:  E H MOUGEY; J W MASON
Journal:  Anal Biochem       Date:  1963-09       Impact factor: 3.365

3.  The metabolism of thyroid hormones. 2. Detection of thyroxine and tri-iodothyronine in human plasma.

Authors:  N F MACLAGAN; C H BOWDEN; J H WILKINSON
Journal:  Biochem J       Date:  1957-09       Impact factor: 3.857

4.  Paperchromatographic determination of thyroid hormone (3,5,3'-triiodothyronine) in serum without radio-iodine.

Authors:  K PIND
Journal:  Acta Endocrinol (Copenh)       Date:  1957-11

5.  The identification of 3:5:3'-L-triiodothyronine in human plasma.

Authors:  J GROSS; R PITT-RIVERS
Journal:  Lancet       Date:  1952-03-01       Impact factor: 79.321

6.  Role of thyroxine-binding globulin in the early distribution of thyroxine and triiodothyronine.

Authors:  B U Musa; R S Kumar; J T Dowling
Journal:  J Clin Endocrinol Metab       Date:  1969-05       Impact factor: 5.958

7.  Absorption of triiodothyronine in man.

Authors:  M T Hays
Journal:  J Clin Endocrinol Metab       Date:  1970-05       Impact factor: 5.958

8.  Specific antibodies to triiodothyronine hormone.

Authors:  B L Brown; R P Ekins; S M Ellis; W S Reith
Journal:  Nature       Date:  1970-04-25       Impact factor: 49.962

9.  Technical aspects of the estimation of triiodothyronine in human serum: evidence of conversion of thyroxine to triiodothyronine during assay.

Authors:  P R Larsen
Journal:  Metabolism       Date:  1971-06       Impact factor: 8.694

10.  The peripheral metabolism of triiodothyronine in normal subjects and in patients with hyperthyroidism.

Authors:  K A Woeber; R J Sobel; S H Ingbar; K Sterling
Journal:  J Clin Invest       Date:  1970-04       Impact factor: 14.808

View more
  23 in total

1.  The radioimmunoassay of triiodothyronine and its clinical application.

Authors:  C J Eastman; J M Corcoran; R P Ekins; E S Williams; J D Nabarro
Journal:  J Clin Pathol       Date:  1975-03       Impact factor: 3.411

2.  Pharmacokinetics of L-Triiodothyronine in Patients Undergoing Thyroid Hormone Therapy Withdrawal.

Authors:  Benjamin Van Tassell; George F Wohlford; Joyce D Linderman; Sheila Smith; Sahzene Yavuz; Frank Pucino; Francesco S Celi
Journal:  Thyroid       Date:  2019-09-12       Impact factor: 6.568

3.  Reduction in extrathyroidal triiodothyronine production by propylthiouracil in man.

Authors:  M Saberi; F H Sterling; R D Utiger
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

4.  Thyroid hormone inhibition of the prolactin response to thyrotropin-releasing hormone.

Authors:  P J Snyder; L S Jacobs; R D Utiger; W H Daughaday
Journal:  J Clin Invest       Date:  1973-09       Impact factor: 14.808

5.  Metabolism and excretion of exogenous thyrotropin-releasing hormone in humans.

Authors:  R M Bassiri; R D Utiger
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808

6.  Repetitive administration of thyrotropin-releasing hormone results in small elevations of serum thyroid hormones and in marked inhibition of thyrotropin response.

Authors:  P J Snyder; R D Utiger
Journal:  J Clin Invest       Date:  1973-09       Impact factor: 14.808

7.  Serum triiodothyronine determination in clinical use.

Authors:  J E Stafford; S Lees; D Watson
Journal:  J Clin Pathol       Date:  1976-07       Impact factor: 3.411

8.  Circadian rhythms of anterior pituitary hormone secretion: effects of dexamethasone.

Authors:  G Tolis; K Banovac; J M McKenzie; H Guyda
Journal:  J Endocrinol Invest       Date:  1979 Oct-Dec       Impact factor: 4.256

9.  Stimulation of thyroid hormone secretion by thyrotropin in beluga whales, Delphinapterus leucas.

Authors:  D J St Aubin
Journal:  Can J Vet Res       Date:  1987-07       Impact factor: 1.310

10.  Triiodothyronine and thyroxine in the serum and thyroid glands of iodine-deficient rats.

Authors:  G M Abrams; P R Larsen
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.